✦ LIBER ✦

Hyperkalemia Associated with Rapid Infusion of Conventional and Lipid Complex Formulations of Amphotericin B

✍ Scribed by John P. Barcia

Book ID: 112113868
Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 238 KB
Volume: 18
Category: Article
ISSN: 0277-0008
DOI: 10.1002/j.1875-9114.1998.tb03915.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adverse drug reactions associated with t

Adverse drug reactions associated with the administration of amphotericin B lipid complex (Abelcet)

✍ Cook, G; Franklin, I M 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 19 KB

Successful treatment of Trichosporon muc

Successful treatment of Trichosporon mucoides infection with lipid complex amphotericin B and 5-fluorocytosine

✍ Tanil Kendirli; Ergin Ciftçi; Erdal İnce; Selim Öncel; Nazan Dalgiç; Haluk Güriz 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Interaction of amphotericin B lipid form

Interaction of amphotericin B lipid formulations and triazoles with human polymorphonuclear leucocytes for antifungal activity against Zygomycetes

✍ Maria Simitsopoulou; Emmanuel Roilides; Avgi Maloukou; Cristina Gil-Lamaignere; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Successful treatment of invasive aspergi

Successful treatment of invasive aspergillosis complicating prolonged treatment-related neutropenia in acute myelogenous leukemia with amphotericin B lipid complex

✍ Hospenthal, Duane R. ;Byrd, John C. ;Weiss, Raymond B. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 365 KB

## Abstract Herein we report the successful treatment of invasive aspergillosis with the liposomal amphotericin B (AMB) formulation, Amphotericin B Lipid Complex (ABLC™). This investigational compound was employed in a 50‐year‐old patient with acute myelomonocytic leukemia complicated by prolonged,

Amphotericin B lipid complex as prophyla

Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy

✍ Gloria N. Mattiuzzi; Hagop Kantarjian; Stefan Faderl; JoAnn Lim; Dimitrios Konto 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract ## BACKGROUND The optimal antifungal prophylactic regimen for patients with acute myelogenous leukemia (AML) or high‐risk myelodysplastic syndrome (MDS) undergoing induction chemotherapy has yet to be identified. A prospective historical control study evaluated the efficacy and safety

Assessing the antifungal activity and to

Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet®) in combination with caspofungin in experimental systemic aspergillosis

✍ Olena Sivak; Karen Bartlett; Verica Risovic; Eugene Choo; Fawziah Marra; D. Scot 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

The purpose of this study was to assess the antifungal activity and renal and hepatic toxicity of amphotericin B lipid complex (ABLC; Abelcet 1 ) following coadministration of Caspofungin to rats infected with Aspergillus fumigatus. Aspergillus fumigatus inoculum (1.3-2.3 Â 10 7 colony forming units